The Supreme Court recently asked the Bombay High Court and Maharashtra government to take corrective steps to tackle non-production of accused before trial cour ...
The press release emphasizes the company’s reliance on a third-party manufacturer for its clinical trial materials, which may signal a lack of in-house production capabilities. Forward-looking ...
TSMC has successfully conducted a trial chip production of its 2nm N2 process with a 60% yield rate. A new report backed by supply chain insiders claims that TSMC has achieved better than ...